Arcapta Neohaler Inhalation Powder, Capsule 75Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

ARCAPTA NEOHALER: Inhalation powder, capsule (75mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Arcapta Powder for Inhalation

What is this Medicine?

INDACATEROL (IN da CA ter ol) is a slow-acting bronchodilator. It helps to open up the airways of your lungs. This medicine is used to treat COPD. It should not be used alone for asthma. Do NOT use for an acute asthma attack. Do NOT use for a COPD attack.

CVS Pharmacy Patient Statistics for ARCAPTA NEOHALER: Inhalation powder, capsule(75mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Arcapta Neohaler 75mcg Powder for Inhalation

NDC: 000780619
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Emphysema, Chronic Obstructive Pulmonary Disease (COPD)

Storage Information
Protect from light
Store in a dry place
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Product should always be stored in the blister and only removed immediately before use
Arcapta Neohaler 75mcg Powder for Inhalation

Reported Side Effects for Arcapta Neohaler 75mcg Powder for Inhalation

Increased Blood Sugar Incidence:
<9.9%*
Severity: MODERATE
Onset: DELAYED
Low Potassium Levels Incidence:
<0.2%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
0.2-1.2%*
Severity: MODERATE
Onset: RAPID
Shaking Incidence:
0.5%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
0.7-1.7%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
1.0-1.2%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Muscle Cramps Incidence:
>2.0%*
Severity: MILD
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Diabetes Incidence:
>2.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.4%*
Severity: MILD
Onset: EARLY
Headache Incidence:
5.1%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
5.3%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
6.5-24.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Arcapta Neohaler 75mcg Powder for Inhalation

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Arcapta Neohaler 75mcg Powder for Inhalation(Indacaterol maleate)
Caffeine-containing Foods/Beverages and Beta-agonists(Indacaterol maleate)
Limit excessive Caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) and limit medicines containing additional Caffeine. In caffeine-sensitive persons, taking a high amount of Caffeine with this drug can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with ARCAPTA NEOHALER

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5